
PP126. COMPOUND HETEROZYGOSITY FOR NOVEL AND KNOWN MUTATIONS IN SLC26A4 CAUSE LARGE VESTIBULAR AQUEDUCT UZUMCU A.1, Uyguner O.1, Ulubil-Emiroglu M.2, Hafiz G.2, Baserer N.2, Eris H.1, Basaran S.1, Wollnik B.3,4
1. Department of Medical Genetics; 2. Burcin-Engin Inan Diagnosis and Training Center for Hearing Impaired Children, Department of Ear-Nose-Throat, Istanbul Medical Faculty, Istanbul University, TURKEY; 3. Institute of Human Genetics; 4. Center for Molecular Medicine (CMMC), University of Cologne, GERMANY
e-mail: a.uzumcu@gmail.com
*Corresponding Author: page: 105
|
Abstract
Large vestibular aqueduct (LVAD) is the most common inner ear anomaly, associated with sensorineural or mixed type of hearing impairment with varying degree and age of onset. LVAD is associated either with the hearing loss in Pendred syndrome (PDS) or in DFNB4, which are allellic disorders caused by mutations in SLC26A4 gene encoding iodide/chloride transporter, Pendrin. We ascertained a non-consanguineous Turkish family with three children having different types (sensorineural and mixed) and degrees (moderate, moderate-to-severe and profound) of hearing loss. CT scanning in the affecteds showed enlargement of vestibular aqueduct. The haplotype analysis with STR markers residing PDS/DFNB4 locus identified two haplotypes co-segregating with the LVAD syndrome in the form of compound heterozygosity. Mutation screening in the coding exons of SLC26A4 revealed that the affected sibs were compound heterozygous for previously described p.L445W and novel p.F515C mutations. p.L445W mutation is located in the sulfate transporter family domain and might be associated with thyroid goiter in homozygous state. The F515 residue is located in the eleventh transmembrane domain and was conserved along the evolution. Further clinical evaluation of the affected sibs and the frequency of p.F515C mutation in Turkish patients with non-syndromic hearing loss will be presented.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|